Drug therapies in dermatology

Arif Aslam; Christopher E M Griffiths

doi:10.7861/clinmedicine.14-1-47

Drug therapies in dermatology

Research output: Contribution to journal › Article › peer-review

Abstract

This article explores the current and emerging therapies for skin disease, with a particular focus on chronic plaque psoriasis and metastatic malignant melanoma. We discuss the current biological therapies used for psoriasis and those on the horizon, including small molecules and biosimilars. We also summarise the recent advances in the use of novel therapeutic agents in other dermatological diseases and outline the promise of translational research and stratified medicine approaches in dermatology. Better matching of patients with therapies is anticipated to have a major effect on both clinical practice and the development of new drugs and diagnostics. © Royal College of Physicians 2014. All rights reserved.

Original language	English
Pages (from-to)	47-53
Number of pages	6
Journal	Clinical Medicine, Journal of the Royal College of Physicians of London
Volume	14
Issue number	1
DOIs	https://doi.org/10.7861/clinmedicine.14-1-47
Publication status	Published - 1 Feb 2014

Keywords

Atopic dermatitis
Biological therapies
Malignant melanoma
Psoriasis
Tumour necrosis factor antagonists

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.7861/clinmedicine.14-1-47

http://www.clinmed.rcpjournal.org/content/14/1/47.full.pdf+html

Cite this

@article{27e4248d9758435baf7467019f1cd251,

title = "Drug therapies in dermatology",

abstract = "This article explores the current and emerging therapies for skin disease, with a particular focus on chronic plaque psoriasis and metastatic malignant melanoma. We discuss the current biological therapies used for psoriasis and those on the horizon, including small molecules and biosimilars. We also summarise the recent advances in the use of novel therapeutic agents in other dermatological diseases and outline the promise of translational research and stratified medicine approaches in dermatology. Better matching of patients with therapies is anticipated to have a major effect on both clinical practice and the development of new drugs and diagnostics. {\textcopyright} Royal College of Physicians 2014. All rights reserved.",

keywords = "Atopic dermatitis, Biological therapies, Malignant melanoma, Psoriasis, Tumour necrosis factor antagonists",

author = "Arif Aslam and Griffiths, {Christopher E M}",

year = "2014",

month = feb,

day = "1",

doi = "10.7861/clinmedicine.14-1-47",

language = "English",

volume = "14",

pages = "47--53",

journal = "Clinical Medicine, Journal of the Royal College of Physicians of London",

issn = "1470-2118",

publisher = "Elsevier BV",

number = "1",

}

TY - JOUR

T1 - Drug therapies in dermatology

AU - Aslam, Arif

AU - Griffiths, Christopher E M

PY - 2014/2/1

Y1 - 2014/2/1

N2 - This article explores the current and emerging therapies for skin disease, with a particular focus on chronic plaque psoriasis and metastatic malignant melanoma. We discuss the current biological therapies used for psoriasis and those on the horizon, including small molecules and biosimilars. We also summarise the recent advances in the use of novel therapeutic agents in other dermatological diseases and outline the promise of translational research and stratified medicine approaches in dermatology. Better matching of patients with therapies is anticipated to have a major effect on both clinical practice and the development of new drugs and diagnostics. © Royal College of Physicians 2014. All rights reserved.

AB - This article explores the current and emerging therapies for skin disease, with a particular focus on chronic plaque psoriasis and metastatic malignant melanoma. We discuss the current biological therapies used for psoriasis and those on the horizon, including small molecules and biosimilars. We also summarise the recent advances in the use of novel therapeutic agents in other dermatological diseases and outline the promise of translational research and stratified medicine approaches in dermatology. Better matching of patients with therapies is anticipated to have a major effect on both clinical practice and the development of new drugs and diagnostics. © Royal College of Physicians 2014. All rights reserved.

KW - Atopic dermatitis

KW - Biological therapies

KW - Malignant melanoma

KW - Psoriasis

KW - Tumour necrosis factor antagonists

U2 - 10.7861/clinmedicine.14-1-47

DO - 10.7861/clinmedicine.14-1-47

M3 - Article

C2 - 24532745

SN - 1470-2118

VL - 14

SP - 47

EP - 53

JO - Clinical Medicine, Journal of the Royal College of Physicians of London

JF - Clinical Medicine, Journal of the Royal College of Physicians of London

IS - 1

ER -

Drug therapies in dermatology

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this